{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T04:16:56Z","timestamp":1648959416525},"reference-count":26,"publisher":"The Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Context: Retention of technetium-99m-sestamibi (99mTc-sestamibi) by parathyroid adenomas appears to be due to the loss of at least one membrane transporter, multidrug resistance 1 (MDR1), and possibly another, multidrug resistance-associated protein 1 (MRP1).<\/jats:p>\n               <jats:p>Objective: The objective was to determine whether hypermethylation of either gene plays a role in their expression and 99mTc-sestamibi retention.<\/jats:p>\n               <jats:p>Design: This was a retrospective study on a convenience sample of paraffin-embedded parathyroid glands.<\/jats:p>\n               <jats:p>Setting: The study was performed at the John Wayne Cancer Institute at Saint John\u2019s Health Center (Santa Monica, CA).<\/jats:p>\n               <jats:p>Patients: Forty-eight patients with primary hyperparathyroidism and five patients without parathyroid disease undergoing thyroid surgery provided 27 adenomatous, 10 hyperplastic, and 16 normal parathyroid glands.<\/jats:p>\n               <jats:p>Intervention: We performed immunohistochemistry, real-time quantitative RT-PCR, and methylation-specific PCR for MDR1 and MRP1 on archival parathyroid tissue and correlated these results with the patient\u2019s 99mTc-sestamibi scan.<\/jats:p>\n               <jats:p>Main Outcome Measure: The main outcome measure was to determine whether hypermethylation of the genes for either transporter is associated with loss of their expression and with a positive 99mTc-sestamibi scan.<\/jats:p>\n               <jats:p>Results: The MDR1 gene was methylated in none of 12 normal glands, 19 of 27 adenomas, and three of 10 hyperplastic glands. Methylation of the MRP1 gene was uncommon (five of 48 tested glands). Methylation of the gene affected the transcript level only for MDR1. Among all glands, hypermethylation for MDR1 was more likely in 99mTc-sestamibi-positive scans (P &amp;lt; 0.001).<\/jats:p>\n               <jats:p>Conclusion: In parathyroid tissue, hypermethylation of the MDR1 gene decreases its expression and is associated with increased detection of parathyroid adenomas by 99mTc-sestamibi parathyroid scans.<\/jats:p>","DOI":"10.1210\/jc.2006-2010","type":"journal-article","created":{"date-parts":[[2007,2,14]],"date-time":"2007-02-14T02:57:43Z","timestamp":1171421863000},"page":"1785-1790","source":"Crossref","is-referenced-by-count":3,"title":["Hypermethylation of Adenosine Triphosphate-Binding Cassette Transporter Genes in Primary Hyperparathyroidism and Its Effect on Sestamibi Imaging"],"prefix":"10.1210","volume":"92","author":[{"given":"Hiroya","family":"Takeuchi","sequence":"first","affiliation":[{"name":"Department of Molecular Oncology (H.T., D.S.B.H., N.U.), John Wayne Cancer Institute at Saint John\u2019s Health Center, Santa Monica, California 90404"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy C.","family":"Greep","sequence":"additional","affiliation":[{"name":"the Breast and Endocrine Program (N.C.G., N.M.H., A.E.G., F.R.S.), John Wayne Cancer Institute at Saint John\u2019s Health Center, Santa Monica, California 90404"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dave S. B.","family":"Hoon","sequence":"additional","affiliation":[{"name":"Department of Molecular Oncology (H.T., D.S.B.H., N.U.), John Wayne Cancer Institute at Saint John\u2019s Health Center, Santa Monica, California 90404"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armando E.","family":"Giuliano","sequence":"additional","affiliation":[{"name":"the Breast and Endocrine Program (N.C.G., N.M.H., A.E.G., F.R.S.), John Wayne Cancer Institute at Saint John\u2019s Health Center, Santa Monica, California 90404"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nora M.","family":"Hansen","sequence":"additional","affiliation":[{"name":"the Breast and Endocrine Program (N.C.G., N.M.H., A.E.G., F.R.S.), John Wayne Cancer Institute at Saint John\u2019s Health Center, Santa Monica, California 90404"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoyuki","family":"Umetani","sequence":"additional","affiliation":[{"name":"Department of Molecular Oncology (H.T., D.S.B.H., N.U.), John Wayne Cancer Institute at Saint John\u2019s Health Center, Santa Monica, California 90404"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick R.","family":"Singer","sequence":"additional","affiliation":[{"name":"the Breast and Endocrine Program (N.C.G., N.M.H., A.E.G., F.R.S.), John Wayne Cancer Institute at Saint John\u2019s Health Center, Santa Monica, California 90404"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"2020071614263295700_R1","first-page":"N126","article-title":"Surgery in primary hyperparathyroidism: the patient without previous neck surgery","volume":"2","author":"Udelsman","year":"2002","journal-title":"J Bone Miner Res 17 Suppl"},{"key":"2020071614263295700_R2","first-page":"7","article-title":"Primary hyperparathyroidism: preoperative localization using technetium-sestamibi scanning.","volume":"80","author":"Mitchell","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614263295700_R3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/00006231-200302000-00003","article-title":"Biological factors influencing parathyroid localization.","volume":"24","author":"Pons","year":"2003","journal-title":"Nucl Med Commun"},{"key":"2020071614263295700_R4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF02439546","article-title":"Comparison and histopathological correlation of three parathyroid imaging methods in a population with a high prevalence of concomitant thyroid diseases.","volume":"24","author":"Staudenherz","year":"1997","journal-title":"Eur J Nucl Med"},{"key":"2020071614263295700_R5","first-page":"1646","article-title":"Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium(I) in cultured mouse fibroblasts.","volume":"31","author":"Chiu","year":"1990","journal-title":"J Nucl Med"},{"key":"2020071614263295700_R6","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1161\/01.CIR.82.5.1826","article-title":"Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium(I) in cultured chick myocardial cells. Mitochondrial and plasma membrane potential dependence.","volume":"82","author":"Piwnica-Worms","year":"1990","journal-title":"Circulation"},{"key":"2020071614263295700_R7","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1067\/msy.2001.118371","article-title":"In vitro accumulation of technetium-99m-sestamibi in human parathyroid mitochondria.","volume":"130","author":"Hetrakul","year":"2001","journal-title":"Surgery"},{"key":"2020071614263295700_R8","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0039-6060(96)80052-3","article-title":"Mechanism of technetium 99m sestamibi parathyroid imaging and the possible role of p-glycoprotein.","volume":"120","author":"Mitchell","year":"1996","journal-title":"Surgery"},{"key":"2020071614263295700_R9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00268-001-0177-2","article-title":"Relation between technetium 99m-methoxyisobutylisonitrile accumulation and multidrug resistance protein in the parathyroid glands.","volume":"26","author":"Yamaguchi","year":"2002","journal-title":"World J Surg"},{"key":"2020071614263295700_R10","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1046\/j.1440-1622.1999.01652.x","article-title":"Pre-operative localization and tissue uptake study in parathyroid imaging with technetium-99m-sestamibi.","volume":"69","author":"Takami","year":"1999","journal-title":"Aust NZ J Surg"},{"key":"2020071614263295700_R11","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0969-8051(01)00259-1","article-title":"Correlation between P-glycoprotein (P-gp) expression in parathyroid and Tc-99m MIBI parathyroid image findings.","volume":"28","author":"Sun","year":"2001","journal-title":"Nucl Med Biol"},{"key":"2020071614263295700_R12","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1007\/s00259-002-0817-2","article-title":"Technetium-99m methoxyisobutylisonitrile imaging for parathyroid adenoma: relationship to P-glycoprotein or multidrug resistance-related protein expression.","volume":"29","author":"Kao","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2020071614263295700_R13","first-page":"1617","article-title":"Technetium-99m-sestamibi parathyroid scintigraphy: effect of P- glycoprotein, histology and tumor size on detectability.","volume":"39","author":"Bhatnagar","year":"1998","journal-title":"J Nucl Med"},{"key":"2020071614263295700_R14","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/archsurg.139.11.1175","article-title":"Clinicopathologic and radiopharmacokinetic factors affecting \u03b3 probe-guided parathyroidectomy.","volume":"139","author":"Ugur","year":"2004","journal-title":"Arch Surg"},{"key":"2020071614263295700_R15","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1056\/NEJMra023075","article-title":"Gene silencing in cancer in association with promoter hypermethylation.","volume":"349","author":"Herman","year":"2003","journal-title":"N Engl J Med"},{"key":"2020071614263295700_R16","first-page":"441","article-title":"Expression of differentiation melanoma-associated antigen genes is associated with favorable disease outcome in advanced-stage melanomas.","volume":"63","author":"Takeuchi","year":"2003","journal-title":"Cancer Res"},{"key":"2020071614263295700_R17","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1200\/JCO.2004.12.009","article-title":"Prognostic significance of molecular upstaging of paraffin-embedded sentinel lymph nodes in melanoma patients.","volume":"22","author":"Takeuchi","year":"2004","journal-title":"J Clin Oncol"},{"key":"2020071614263295700_R18","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.1200\/JCO.2003.01.063","article-title":"Prediction of disease outcome in melanoma patients by molecular analysis of paraffin-embedded sentinel lymph nodes.","volume":"21","author":"Kuo","year":"2003","journal-title":"J Clin Oncol"},{"key":"2020071614263295700_R19","first-page":"1639","article-title":"Epigenetic inactivation of RAS association domain family protein 1 (RASSF1A) in malignant cutaneous melanoma.","volume":"63","author":"Spugnardi","year":"2003","journal-title":"Cancer Res"},{"key":"2020071614263295700_R20","doi-asserted-by":"crossref","first-page":"39990","DOI":"10.1074\/jbc.M103181200","article-title":"Methylation-dependent silencing of the reduced folate carrier gene in inherently methotrexate-resistant human breast cancer cells.","volume":"276","author":"Worm","year":"2001","journal-title":"J Biol Chem"},{"key":"2020071614263295700_R21","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1182\/blood.V92.11.4296","article-title":"Hypomethylation status of CpG sites at the promoter region and overexpression of the human MDR1 gene in acute myeloid leukemias.","volume":"92","author":"Nakayama","year":"1998","journal-title":"Blood"},{"key":"2020071614263295700_R22","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1038\/sj.onc.1207505","article-title":"Profiling epigenetic inactivation of tumor suppressor genes in tumors and plasma from cutaneous melanoma patients.","volume":"23","author":"Hoon","year":"2004","journal-title":"Oncogene"},{"key":"2020071614263295700_R23","author":"Greep","year":"2005"},{"key":"2020071614263295700_R24","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0039-6060(03)00422-7","volume":"134","author":"Carling","journal-title":"Surgery"},{"key":"2020071614263295700_R25","first-page":"2000","article-title":"Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism.","volume":"85","author":"Carling","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614263295700_R26","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/107327480301000207","article-title":"Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting p-glycoprotein.","volume":"10","author":"Thomas","year":"2003","journal-title":"Cancer Control"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/92\/5\/1785\/9053739\/jcem1785.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/92\/5\/1785\/9053739\/jcem1785.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T02:18:40Z","timestamp":1594952320000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/92\/5\/1785\/2598604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,1]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2006-2010","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5,1]]}}}